Zdrowie i gospodarka · 06/08/2001
FDA Amends Blood Regulations to Align with Industry Practices
The Food and Drug Administration (FDA) is updating its biologics regulations to remove outdated requirements and align with current practices in the blood industry, as part of its 'Blood Initiative' to review and revise regulations related to blood, blood components, and Source Plasma.